Login / Signup

Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States.

April W ArmstrongManish PatelChao LiVishvas GargMonika Rao MandavaJashin J Wu
Published in: The Journal of dermatological treatment (2023)
Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors.
Keyphrases
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • prognostic factors
  • patient reported outcomes
  • atopic dermatitis